SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-13-000067
Filing Date
2013-08-07
Accepted
2013-08-07 14:20:03
Documents
15
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q valeantq22013.htm 10-Q 2413037
2 EXHIBIT 10.3 exhibit103.htm EX-10.3 1463191
3 EXHIBIT 10.4 exhibit104.htm EX-10.4 1610508
4 EXHIBIT 10.5 exhibit105.htm EX-10.5 188760
5 EXHIBIT 10.6 exhibit106.htm EX-10.6 202106
6 EXHIBIT 31.1 exhibit311.htm EX-31.1 14164
7 EXHIBIT 31.2 exhibit312.htm EX-31.2 14262
8 EXHIBIT 32.1 exhibit321.htm EX-32.1 8539
9 EXHIBIT 32.2 exhibit322.htm EX-32.2 8519
  Complete submission text file 0000885590-13-000067.txt   30888898

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT vrx-20130630.xml EX-101.INS 3598338
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20130630.xsd EX-101.SCH 89610
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20130630_cal.xml EX-101.CAL 116367
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20130630_lab.xml EX-101.LAB 1078165
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20130630_pre.xml EX-101.PRE 631414
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20130630_def.xml EX-101.DEF 462966
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 131016936
SIC: 2834 Pharmaceutical Preparations